COMMUNIQUÉS West-GlobeNewswire

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2018 Financial and Operating Results
26/03/2019
CHARLESTON, S.C., March 26, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today reported its financial and operating results for the fourth quarter and year ended December 31, 2018. All [...]
Harvard Bioscience To Showcase Products at Experimental Biology 2019
26/03/2019
All Three Commercial Units to Be Represented HOLLISTON, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to [...]
Lutronic Vision Engages World Renowned Retina Expert for R:GEN™ Pilot AMD Clinical Study
26/03/2019
-Key opinion leader Professor Robyn Guymer expected to serve as study’s principal investigator- BILLERICA, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Lutronic Vision (“Lutronic” or “the Company”), a wholly-owned [...]
Precision Therapeutics Inc. Announces Proposed Public Offering of Securities
26/03/2019
MINNEAPOLIS, March 26, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”) today announced a proposed public offering of its common stock and warrants to purchase common [...]
ImmuCell Corporation Announces Commencement of Public Offering of Common Stock
26/03/2019
PORTLAND, Maine, March 26, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Selecta Biosciences Announces New Employment Inducement Grant
26/03/2019
WATERTOWN, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by mitigating [...]
PhaseBio Reports Fourth Quarter and Full-Year 2018 Financial and Business Results
26/03/2019
Results from Phase 1 clinical trial of PB2452 published in the New England Journal of Medicine and presented at the American College of Cardiology’s Annual Scientific Session Initiated Phase 2b trial of PB1046 for the [...]
ProQR spins out all Dystrophic Epidermolysis Bullosa activities into newly formed Wings Therapeutics created by EB Research Partnership
26/03/2019
LEIDEN, Netherlands and CAMBRIDGE, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
Agios Receives FDA Breakthrough Therapy Designation for TIBSOVO® (ivosidenib) in Combination with Azacitidine for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) with an IDH1 Mutation in Adult Patients Ineligible for Intensive Chemotherapy
26/03/2019
CAMBRIDGE, Mass., March 26, 2019 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the U.S. Food [...]
Guerbet: 2018 annual results
26/03/2019
2018 annual results Growth and EBITDA in line with announced targets Reported revenue: €789.6 million Revenue at constant exchange rates: €825.7 million; +2.3%, in line with the guidance given at Capital Markets Day in [...]
GUERBET: Résultats annuels 2018
26/03/2019
Résultats annuels 2018 Croissance et EBITDA conformes aux objectifs annoncés Chiffre d’affaires publié : 789,6 M€ Chiffre d’affaires à taux de change constant : 825,7 M€ ; +2,3%, en ligne avec la guidance donnée lors du [...]
I-PEN® Osmolarity System Now Available in Brazil Through Partnership with DryCom
26/03/2019
MONTREAL, March 26, 2019 (GLOBE NEWSWIRE) -- I-MED Pharma, Inc., a Canadian company specializing in dry eye diagnosis and management, announced today the signing of an exclusive agreement with DryCom - Dry Eye Solutions [...]
OSE Immunotherapeutics Announces New Research Collaboration with Léon Bérard Cancer Center to Use Artificial Intelligence Technologies to Identify Novel Immuno-Oncology Targets
26/03/2019
Findings from the collaboration will provide relevant information, especially for the development of novel bispecific antibodies (BiCKI® platform) NANTES, France, March 26, 2019 (GLOBE NEWSWIRE) -- OSE [...]
VALNEVA annonce la publication de son Document de Référence 2018
26/03/2019
Valneva annonce la publication de son Document de Référence 2018 Saint Herblain (France), 26 mars 2019 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie développant et commercialisant des vaccins contre [...]
Blueberries Medical to Acquire Cannabis Cultivation, Processing & Manufacturing Rights for 3.2 Million Square Foot Property in Argentina
26/03/2019
TORONTO, March 26, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a leading Colombia based licensed producer of medicinal cannabis and [...]
Nexstim Plc: Nexstim Plc publishes prospectus regarding EUR 5.2 million rights issue and new information regarding previous profit forecast
26/03/2019
Company announcement, Helsinki, 26 March 2019 at 6.00 PM Nexstim Plc: Nexstim Plc publishes prospectus regarding EUR 5.2 million rights issue and new information regarding previous profit forecast Nexstim Plc (NXTMH:HEX [...]
Orion Corporation: Organising meeting of the Board of Directors
26/03/2019
Orion Corporation Stock Exchange Release 26 March 2019 at 5.30 p.m. EET Orion Corporation: Organising meeting of the Board of Directors In its organising meeting, the Board of Directors of Orion Corporation, which was [...]
Memorandum of Understanding for Confirmatory Trial to Support Marketing Approval of Revascor for Reduction of Gastrointestinal Bleeding in LVAD Patients
26/03/2019
NEW YORK and MELBOURNE, Australia, March 26, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in cellular medicines for inflammatory diseases, today announced that the International [...]
Orion Corporation: Decisions by the AGM on 26 March 2019
26/03/2019
Orion Corporation Stock Exchange Release 26 March at 4.45 p.m. EET Orion Corporation: Decisions by the AGM on 26 March 2019 At the Annual General Meeting of Orion Corporation held today, the following decisions were [...]

Pages